Medicare Enrolled
Dr. Majed Chane, M.D.
Interventional Cardiology · Huntington Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chane
Dr. Majed Chane is an interventional cardiology specialist in Huntington Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chane performed 5,488 Medicare services across 2,863 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chane received a total of $6,932 from 39 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in CA
$6,932 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,488
Medicare services
Top 22% in CA for interventional cardiology
2,863
Unique beneficiaries
$167
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~289 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
841 | $100 | $568 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
800 | $101 | $604 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
471 | $66 | $393 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
296 | $44 | $1,090 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
285 | $163 | $1,173 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
272 | $159 | $1,344 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
271 | $12 | $97 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
237 | $142 | $1,102 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
228 | $187 | $840 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
213 | $243 | $2,906 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
193 | $108 | $715 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
173 | $41 | $213 |
| External counterpulsation, per treatment session | 146 | $97 | $827 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
144 | $1,560 | $12,581 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
118 | $61 | $440 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $67 | $410 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $141 | $808 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $120 | $911 |
| Ultrasound-guided injection into a single leg vein A chemical agent is injected into one incompetent vein in the leg while using ultrasound to guide the needle placement. |
70 | $1,227 | $9,462 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
62 | $177 | $1,511 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
42 | $90 | $220 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
38 | $983 | $9,026 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
35 | $19 | $142 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
32 | $771 | $4,358 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
31 | $74 | $475 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
31 | $24 | $158 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
31 | $12 | $81 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
29 | $172 | $1,202 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
28 | $54 | $330 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
19 | $10 | $303 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
18 | $222 | $1,546 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
16 | $67 | $941 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
16 | $12 | $181 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
14 | $18 | $121 |
| New patient office visit, complex (60-74 min) | 11 | $172 | $1,143 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.5% high complexity
30.7% medium
63.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,932
Total received (2018-2024)
Avg $990/year across 7 years
Top 48% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,932 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,021
2023
$1,270
2022
$645
2021
$809
2020
$494
2019
$1,228
2018
$1,466
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$191
ATRICURE, INC.
$189
AstraZeneca Pharmaceuticals LP
$115
Bard Peripheral Vascular, Inc.
$74
Amgen Inc.
$72
E.R. Squibb & Sons, L.L.C.
$70
Novartis Pharmaceuticals Corporation
$58
SCPHARMACEUTICALS INC.
$54
Merck Sharp & Dohme LLC
$47
Novo Nordisk Inc
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
Edwards Lifesciences Corporation
$23
ABIOMED
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Top 3 companies account for 48.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$741
Janssen Pharmaceuticals, Inc
$662
AstraZeneca Pharmaceuticals LP
$516
Amgen Inc.
$455
PFIZER INC.
$388
E.R. Squibb & Sons, L.L.C.
$378
Medtronic Vascular, Inc.
$373
Medtronic, Inc.
$370
Bard Peripheral Vascular, Inc.
$331
Biocompatibles, Inc.
$284
Edwards Lifesciences Corporation
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$229
SANOFI-AVENTIS U.S. LLC
$202
ATRICURE, INC.
$189
Merck Sharp & Dohme LLC
$166
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$165
Gilead Sciences, Inc.
$157
Organogenesis Inc.
$125
BOSTON SCIENTIFIC CORPORATION
$119
Novo Nordisk Inc
$94
Regeneron Healthcare Solutions, Inc.
$92
Tactile Systems Technology Inc
$55
SCPHARMACEUTICALS INC.
$54
Alnylam Pharmaceuticals Inc.
$51
Merck Sharp & Dohme Corporation
$49
Allergan Inc.
$47
BIOTRONIK INC.
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
Amarin Pharma Inc.
$43
Resmed Corp
$35
Arrow International, Inc.
$33
Venclose Inc.
$31
ACIST MEDICAL SYSTEMS, INC.
$27
Kestra Medical Technology Services, Inc.
$21
ABIOMED
$19
Medtronic USA, Inc.
$19
AngioDynamics, Inc.
$18
Relypsa, Inc.
$16
Smith+Nephew, Inc.
$16
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
AIR 11 · AMVUTTRA · ATRICLIP LAA EXCLUSION SYSTEM · Advisa · Apligraf · Assure WCD · Azure · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CLOSUREFAST · Catheter - ClosureFast · ClosureFast · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVRSF · FARXIGA · FLEXITOUCH · FUROSCIX · Flexitouch Plus · INVOKANA · Impella · JARDIANCE · Kerendia · LEQVIO · LifeVest · MULTAQ · OFEV · ONPATTRO · Ozempic · PICO 7 Single Use Negative Pressure Wound Therapy · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PlasmaBlade · RXI SYSTEMS · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · VARITHENA · VENASEAL · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · VenaSeal · Venclose Maven Catheter · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
66
Per 100K population
2.1
County median income
$113,702
Nearest hospital
HUNTINGTON BEACH HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chane is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chane experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Chane performed 841 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chane receive payments from pharmaceutical companies?
Yes. Dr. Chane received a total of $6,932 from 39 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chane's costs compare to other interventional cardiologists in Huntington Beach?
Dr. Chane's average Medicare payment per service is $167. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Huntington Beach
Browse interventional cardiologists in Huntington Beach ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology